Activities per year
Activities
- 1 - 50 out of 183 results
Search results
-
Innovative applications of global assays in hemostatis
Jonathan Douxfils (Jury Member)
15 Dec 2023Activity: Examinations › External Thesis
-
Impact of progestagen alone or associated with estrogen on the coagulation: A state of the art in 2023
Jonathan Douxfils (Speaker)
1 Dec 2023Activity: Talk or presentation types › Invited talk
-
Hemostasis parameters with estetrol/drospirenone - why APC resistance matters
Jonathan Douxfils (Speaker)
30 Nov 2023Activity: Talk or presentation types › Invited talk
-
Prediction of venous thromboembolism risk associated with combined oral contraceptives: an exploratory model
Laure Morimont (Speaker) & Jonathan Douxfils (Speaker)
30 Nov 2023Activity: Talk or presentation types › Oral presentation
-
Risque induit par les oestrogènes de synthèse en clinique
Jonathan Douxfils (Invited speaker)
8 Jun 2023Activity: Talk or presentation types › Invited talk
-
Évaluation du risque vasculaire des contraceptifs
Jonathan Douxfils (Invited speaker)
21 Jun 2023 → 23 Jun 2023Activity: Talk or presentation types › Invited talk
-
Fantastic 4 - E4stetrol in Women's Health
Jonathan Douxfils (Invited speaker) & Jean-Michel Foidart (Invited speaker)
4 May 2023 → 6 May 2023Activity: Talk or presentation types › Oral presentation
-
Acquired APC resistance as a marker for VTE, how does the estrogens differ?
Jonathan Douxfils (Invited speaker)
24 Mar 2023Activity: Talk or presentation types › Oral presentation
-
Estétrol: une nouvelle ère dans la contraception
Jonathan Douxfils (Invited speaker)
11 Feb 2023Activity: Talk or presentation types › Invited talk
-
Thromboembolie veineuse et contraception orale: Quelle stratégie pour minimiser le risque?
Jonathan Douxfils (Invited speaker) & Laure Morimont (Speaker)
12 Jan 2023Activity: Talk or presentation types › Invited talk
-
Global coagulation assays in the future of laboratory diagnostics of hemostasis and thrombosis - Interplay between platelets and coagulation
Jonathan Douxfils (Keynote speaker)
24 Nov 2022Activity: Talk or presentation types › Invited talk
-
Drug monitoring of direct oral anticoagulants: Key considerations and prespectives
Jonathan Douxfils (Speaker)
3 Nov 2022Activity: Talk or presentation types › Invited talk
-
Hormonal contraception and the risk of venous thrombosis – facts and myths
Jonathan Douxfils (Speaker)
18 Nov 2022Activity: Talk or presentation types › Invited talk
-
Low Thrombin Generation in Menopausal Women Using Estetrol (E4)
Laure Morimont (Speaker) & Jonathan Douxfils (Speaker)
26 Oct 2022Activity: Talk or presentation types › Oral presentation
-
Acquired APC resistance as a marker for VTE, how reliable?
Jonathan Douxfils (Speaker)
7 Oct 2022Activity: Talk or presentation types › Invited talk
-
Beeak-out Medical: Hemostasis and update on the Post Authorization Safety Study
Jonathan Douxfils (Speaker) & Guillaume Chatel (Speaker)
13 Sept 2022Activity: Talk or presentation types › Invited talk
-
Method validation for haemostasis assays: Validation and standardization of the ETP-based activated protein C resistance test for the clinical investigation of steroid contraceptives in women. An unmet clinical and regulatory need
Jonathan Douxfils (Speaker)
15 Sept 2022Activity: Talk or presentation types › Invited talk
-
Impact of E4 on hemostasis — Key messages to understand its unique safety profile
Jonathan Douxfils (Speaker)
13 Sept 2022Activity: Talk or presentation types › Invited talk
-
Linking platelet lipid metabolism and thrombosis: Role of acetyl-CoA carboxylase
Jonathan Douxfils (Jury Member)
25 Aug 2022Activity: Examinations › External Thesis
-
ISTH 2022 Congress
Jonathan Douxfils (Contributor)
9 Jul 2022 → 13 Jul 2022Activity: Participating in or organising an event types › Participation in conference
-
ISTH 2022 Congress
Laure Morimont (Participant), Marie Didembourg (Participant) & Jonathan Douxfils (Participant)
9 Jul 2022 → 13 Jul 2022Activity: Participating in or organising an event types › Participation in conference
-
Serum SARS-CoV-2 Antigens for the Determination of COVID-19 Severity
Jonathan Douxfils (Speaker)
4 Jul 2022Activity: Talk or presentation types › Invited talk
-
L’associazione Estetrolo/Drospirenone: approfondimento sui parametri ematocoagulativi | Why APC resistance matters?
Jonathan Douxfils (Speaker)
14 Jun 2022Activity: Talk or presentation types › Invited talk
-
Monitoring des anticoagulants: Artéfacts ou avantages - Anticoagulants directs oraux
Jonathan Douxfils (Speaker)
20 Jun 2022Activity: Talk or presentation types › Invited talk
-
Impact des traitements hormonaux sur l’hémostase et exploration biologique : développement et perspectives actuelles
Jonathan Douxfils (Speaker)
7 Jun 2022Activity: Talk or presentation types › Invited talk
-
Estetrol (E4): a native estrogen whose effect on the liver does not need to be counterbalanced by progestins
Jonathan Douxfils (Speaker)
27 May 2022Activity: Talk or presentation types › Oral presentation
-
Impact des traitements hormonaux sur l’hémostase et exploration biologique : développement et perspectives actuelles
Jonathan Douxfils (Speaker)
17 May 2022Activity: Talk or presentation types › Invited talk
-
Safety profile of E4: recent clinical evidence
Jonathan Douxfils (Speaker)
12 May 2022Activity: Talk or presentation types › Invited talk
-
16th ESC congress
Laure Morimont (Participant) & Jonathan Douxfils (Contributor)
25 May 2022 → 28 May 2022Activity: Participating in or organising an event types › Participation in conference
-
Correlation between activated protein C Resistance and the Relative Risk of Venous Thromboembolism in Women Using Hormonal Therapy
Laure Morimont (Speaker) & Jonathan Douxfils (Speaker)
11 May 2022 → 14 May 2022Activity: Talk or presentation types › Oral presentation
-
11ème symposium annuel du NTHC(Namur Thrombosis & Hemostasis Center)
Laure Morimont (Contributor), Jonathan Evrard (Contributor), Romain Siriez (Contributor), Jonathan Douxfils (Contributor), Marie Didembourg (Participant), Constant GILLOT (Participant), Happy Djokoto (Participant) & Helene Haguet (Participant)
17 May 2022Activity: Participating in or organising an event types › Participation in conference
-
11ème symposium annuel du NTHC(Namur Thrombosis & Hemostasis Center)
Julie Laloy (Participant)
17 May 2022Activity: Participating in or organising an event types › Participation in conference
-
In vitro and in vivo models of cardiac ischemia : Past and Future
Julie Laloy (Speaker)
21 Mar 2022Activity: Talk or presentation types › Invited talk
-
10 ans de monitoring des anticoagulants oraux. Où en sommes-nous et où allons-nous?
Jonathan Douxfils (Speaker)
15 Mar 2022Activity: Talk or presentation types › Invited talk
-
Estétrol/drospirénone, le point de vue de l’hém(ost)ato(sio)logue
Jonathan Douxfils (Speaker)
26 Jan 2022Activity: Talk or presentation types › Invited talk
-
Measurement of Direct Oral Anticoagulants and Contact Pathway Inhibitors
Jonathan Douxfils (Invited speaker)
18 Jul 2021Activity: Talk or presentation types › Invited talk
-
Thrombotic risk associated with COVID- 19 pathogenesis and unusual thrombosis associated with thrombocytopenia in the context of COVID-19 vaccination
Jonathan Douxfils (Invited speaker)
24 Jun 2021Activity: Talk or presentation types › Invited talk
-
Neutralizing Antibodies in COVID-19 Patients and Vaccine Recipients After Two Doses of BNT162b2
Julien Favresse (Invited speaker) & Jonathan Douxfils (Invited speaker)
7 Jun 2021Activity: Talk or presentation types › Invited talk
-
Contribution des techniques de coagulation à la compréhension de la physiologie et de la physiopathologie de l’hémostase – Applications cliniques
Jonathan Douxfils (Jury Member)
4 May 2021Activity: Examinations › External Thesis
-
Estetrol (E4): Impact on hemostasis
Jonathan Douxfils (Invited speaker)
24 May 2021Activity: Talk or presentation types › Invited talk
-
Neutralizing antibodies in COVID-19: Current knowledge and perspectives
Jonathan Douxfils (Invited speaker)
16 Mar 2021Activity: Talk or presentation types › Invited talk
-
Validation and standardization of the ETP-based activated protein C resistance test for the clinical investigation of steroid contraceptives in women: an unmet clinical and regulatory need
Jonathan Douxfils (Invited speaker) & Laure Morimont (Invited speaker)
4 Feb 2021Activity: Talk or presentation types › Invited talk
-
Utilisation des tests chromogéniques anti-FXa dans le cadre du suivi de l’HNF et des HBPM: principes de base et recommandations
Jonathan Douxfils (Invited speaker)
9 Feb 2021Activity: Talk or presentation types › Invited talk
-
Fund for Research Training in Industry and Agriculture (FRIA) (External organisation)
Jonathan Douxfils (Chair)
2021 → 2024Activity: Examinations › Jury
-
Restoring faith in COC - An important hemostasis update
Jonathan Douxfils (Speaker)
2 Dec 2020Activity: Talk or presentation types › Invited talk
-
Monitoring of anticoagulant drugs
Jonathan Douxfils (Speaker)
16 Sept 2020Activity: Talk or presentation types › Invited talk
-
How to Measure Lupus Anticoagulants During DOAC Treatment?
Jonathan Douxfils (Speaker)
12 Jul 2020Activity: Talk or presentation types › Invited talk
-
ISTH 2019 : The XXVII Congress of the International Society on Thrombosis and Haemostasis
Jonathan Douxfils (Invited Speaker)
6 Jul 2019 → 10 Jul 2019Activity: Participating in or organising an event types › Participation in conference
-
ISTH 2019 : The XXVII Congress of the International Society on Thrombosis and Haemostasis
Jonathan Douxfils (Member of Scientific Committee)
6 Jul 2019 → 10 Jul 2019Activity: Participating in or organising an event types › Participation in conference
-
Portola Pharmaceuticals
Jonathan Douxfils (Expert)
7 Jul 2019Activity: Consultancy types › Consultancy